Penumbra
PEN
#1771
Rank
โ‚ฌ8.86 B
Marketcap
231,08ย โ‚ฌ
Share price
-0.08%
Change (1 day)
-2.11%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ0.21 Billion

According to Penumbra's latest financial reports the company's total debt is โ‚ฌ0.21 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Penumbra - Total debt on balance sheet (from 2018 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ0.21 B-3.55%
2022-12-31โ‚ฌ0.21 B43.43%
2021-12-31โ‚ฌ0.15 B143.91%
2020-12-31โ‚ฌ62.82 M-14.48%
2019-12-31โ‚ฌ73.46 M
2018-12-31N/A
2013-12-31โ‚ฌ4.34 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ31.46 M-85.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.78 B 261.35%๐Ÿ‡บ๐Ÿ‡ธ USA